PT  - JOURNAL ARTICLE
AU  - Jacobson, Anne
ED  - Ridker, Paul
TI  - JUPITER Study Continues to Make News
DP  - 2009 Jun 01
TA  - MD Conference Express
PG  - 13--14
VI  - 9
IP  - 2
4099  - http://mdc.sagepub.com/content/9/2/13.short
4100  - http://mdc.sagepub.com/content/9/2/13.full
AB  - This article presents findings from another prespecified analysis of the JUPITER data, assessing the effect of rosuvastatin on symptomatic venous thromboembolism (VTE), which occurred about as often as myocardial infarction or stroke in the JUPITER study. Compared with placebo, rosuvastatin was associated with a 43% reduction (HR, 0.57; 95% CI, 0.37 to 0.86; p=0.007) in risk of VTE and no increase in bleeding [Glynn RJ et al. N Engl J Med 2009].